ask="4.91"
ask_size="9700"
average_daily_volume="60410"
bid="2.80"
bid_size="500"
book_value="1.19"
change="+0.02"
change_from_200_day_moving_average="-0.73"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-2.95"
change_From_52_week_low="0.60"
change_in_percent="+0.57%"
close="3.52"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.54"
high_52_weeks="6.47"
last_trade_date="1/10/2017"
last_trade_price="3.52"
last_trade_size="106"
last_trade_time="4:00pm"
low="3.40"
low_52_weeks="2.92"
market_capitalization="22.16M"
moving_average_200_day="4.25"
moving_average_50_day="3.64"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="3.50"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-17.21%"
percent_change_from_50_day_moving_average="-3.25%"
percent_change_from_52_week_high="-45.64%"
percent_change_from_52_week_low="+20.55%"
previous_close="3.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.94"
price_per_sales="24.33"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="3.84"
stock_exchange="NCM"
symbol="MBVX"
volume="29972"
weeks_range_52="2.92 - 6.47"
